Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Compounding Pharmacies Market — Insights 

A pharmacy that is operated by a licensed pharmacist, licensed physician or a person under the guidance of a licensed pharmacist is called compounding pharmacy.

Statistics:

The global compounding pharmacies market is estimated to account for US$ 13,304.8 Mn in terms of value by the end of 2027.

Global Compounding Pharmacies Market: Drivers

Global shortage of essential drugs is expected to propel growth of the global compounding pharmacies market over the forecast period. For instance, according to the Department of Health and Social Care (DHSC), in November 2019, NHS was facing shortage' of lifesaving drugs that include treatments for cancer, heart conditions and epilepsy.

Increasing prevalence of chronic diseases is expected to boost growth of the market. For instance, according to the World Health Organization, 8.1 million new cases of cancer and 9.6 million deaths due to the disease were recorded in 2018.

North America region held dominant position in the global compounding pharmacies market in 2018, accounting for 65.5% share in terms of value, followed by Europe.

Figure 1. Global Compounding Pharmacies Market Value (US$ Mn), by Region, 2018

Compounding Pharmacies  | Coherent Market Insights

Global Compounding Pharmacies Market: Restraints

Increasing restrictions on manufacturing of complex formulations is expected to hinder growth of the global compounding pharmacies market. For instance, the U.S. FDA noted that compounding drugs containing API acetaminophen in excess of 325mg, which may lead to liver injuries in certain patients. Therefore, it restricts compounding pharmacies from manufacturing certain types of drugs that include copies of FDA-approved prescription drugs, even if they appear on FDA’s shortage list and complex dosage forms such as extended release products, transdermal patches, liposomal products, and most biologics.

Moreover, increasing product recall is also expected to hinder growth of the market. For instance, in August 2019, the U.S. FDA requested recall of sterile compounded drug products produced by Pacifico National Inc. and dba AmEx Pharmacy.

Global Compounding Pharmacies Market: Opportunities

R&D of drugs in innovative medium/forms and varying dosages for the treatment of various diseases is expected to offer lucrative growth opportunity of market players. For instance, in November 2018, AMC, a hospital in Amsterdam focused on producing compounding drugs, received permission from the Dutch Health and Youth Care Inspectorate to produce an equivalent of chenodeoxycholic acid (CDCA) if the used resources meet the quality standards.

Moreover, compounding pharmacies need to adopt hybrid retail formats along with a compounding department in order to diversify their business base. Compounding pharmacies can also focus more on non-sterile compounding to avoid mishaps due to sterile compounding.

Compounding Pharmacies  | Coherent Market Insights

The Topical Medication segment was valued at US$ 3,335.4 Mn in the global compounding pharmacies market in 2018 and is expected to reach US$ 5,784.9 Mn by 2027 at a CAGR of 5.6%.

Global Compounding Pharmacies Market: Market Trends/Key Takeaways

Hospitals in the U.S. are expected to increase outsourcing of compounding services to the U.S. FDA 503B-certified bulk drug manufacturing facilities in the U.S.

The market is also witnessing development of innovative pain management compounded drugs, constituting of unique and currently unapproved combinations. These medications are expected to witness increasing demand from sports medicines and oncology domains.

Global Compounding Pharmacies Market: Regulations

The EU Court of Justice is currently contemplating on mandating that bulk drug substances cannot be manufactured by compounding pharmacies unless they possess a proper manufacturing authorization. These should be accompanied with proper toxicity and pharmacovigilance data. In this regard, France is planning to permit pharmacists to substitute cheaper biosimilars on production of prescriptions for biologics

Global Compounding Pharmacies Market: Competitive Landscape

Major players operating in the global compounding pharmacies market include, Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, and Lorraine’s Pharmacy.

Global Compounding Pharmacies Market: Key Developments

Key players in the market are focused on geographical expansion through M&A activities. For instance, in May 2019, Fagron entered into an agreement to acquire Central de Drogas, S.A. de C.V., a leading supplier of raw materials to compounding pharmacies and the pharmaceutical industry in Mexico.

In April 2019, Pentec Health, Inc., an established leader in sterile compounding with an FDA registered 503B Outsourcing Facility, added California to their list of 43 licensed states.

Compounding pharmacies is a pharmacy operated by registered pharmacist or physician or person under the guidance of registered pharmacist. Compounding pharmacy is slightly differ from traditional pharmacy however the main role of compounding pharmacy is to develop drugs which are prescribed by physician according to patient specific requirement. These compounded drugs are used in dermatology, hormone replacement therapy, and pain management and sometimes it can be used as nutritional supplement. Shortage of drug molecules and rising ease of administration of oral compounded medicines is expected to propel the growth of compounding pharmacies market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global compound pharmacies market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global compound pharmacies market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, and Lorraine’s Pharmacy.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global compound pharmacies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compound pharmacies market

Detailed Segmentation:

  • Global Compound Pharmacies Market, By Products:
    • Oral Medication
      • Capsule
      • Tablets
      • Mixtures
      • Lollipops
      • Lozenges
    • Topical Medication
      • Gels
      • Ointments
      • Cream
      • Lotions
    • Mouthwashes
    • Suppositories
  • Global Compound Pharmacies Market, By Application:
    • Medication for Adults
    • Medication for Veterinary
    • Medication for Children
    • Medication for Geriatric
  • Global Compound Pharmacies Market, By Therapeutic Area:
    • Pain Management
    • Hormone Replacement Therapy
  • Global Compound Pharmacies Market, By Region:
    • North America:
      • By Products:
        • Oral Medication
          • Capsule
          • Tablets
          • Mixtures
          • Lollipops
          • Lozenges
        • Topical Medication
          • Gels
          • Ointments
          • Cream
          • Lotions
        • Mouthwashes
        • Suppositories
      • By Application:
        • Medication for Adults
        • Medication for Veterinary
        • Medication for Children
        • Medication for Geriatric
      • By Therapeutic Area:
        • Pain Management
        • Hormone Replacement Therapy
      • By Country:
        • U.S.
        • Canada
    • Latin America:
      • By Products:
        • Oral Medication
          • Capsule
          • Tablets
          • Mixtures
          • Lollipops
          • Lozenges
        • Topical Medication
          • Gels
          • Ointments
          • Cream
          • Lotions
        • Mouthwashes
        • Suppositories
      • By Application:
        • Medication for Adults
        • Medication for Veterinary
        • Medication for Children
        • Medication for Geriatric
      • By Therapeutic Area:
        • Pain Management
        • Hormone Replacement Therapy
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Products:
        • Oral Medication
          • Capsule
          • Tablets
          • Mixtures
          • Lollipops
          • Lozenges
        • Topical Medication
          • Gels
          • Ointments
          • Cream
          • Lotions
        • Mouthwashes
        • Suppositories
      • By Application:
        • Medication for Adults
        • Medication for Veterinary
        • Medication for Children
        • Medication for Geriatric
      • By Therapeutic Area:
        • Pain Management
        • Hormone Replacement Therapy
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Products:
        • Oral Medication
          • Capsule
          • Tablets
          • Mixtures
          • Lollipops
          • Lozenges
        • Topical Medication
          • Gels
          • Ointments
          • Cream
          • Lotions
        • Mouthwashes
        • Suppositories
      • By Application:
        • Medication for Adults
        • Medication for Veterinary
        • Medication for Children
        • Medication for Geriatric
      • By Therapeutic Area:
        • Pain Management
        • Hormone Replacement Therapy
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Products:
        • Oral Medication
          • Capsule
          • Tablets
          • Mixtures
          • Lollipops
          • Lozenges
        • Topical Medication
          • Gels
          • Ointments
          • Cream
          • Lotions
        • Mouthwashes
        • Suppositories
      • By Application:
        • Medication for Adults
        • Medication for Veterinary
        • Medication for Children
        • Medication for Geriatric
      • By Therapeutic Area:
        • Pain Management
        • Hormone Replacement Therapy
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Products:
        • Oral Medication
          • Capsule
          • Tablets
          • Mixtures
          • Lollipops
          • Lozenges
        • Topical Medication
          • Gels
          • Ointments
          • Cream
          • Lotions
        • Mouthwashes
        • Suppositories
      • By Application:
        • Medication for Adults
        • Medication for Veterinary
        • Medication for Children
        • Medication for Geriatric
      • By Therapeutic Area:
        • Pain Management
        • Hormone Replacement Therapy
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Central Admixture Pharmacy Services *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Fagron
    • Fresenius Kabi AG
    • PharMEDium Services, LLC
    • Institutional Pharmacy Solutions
    • Cantrell Drug Company
    • Triangle Compounding Pharmacies
    • Lorraine’s Pharmacy

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Products
      • Market Snippet, By Application
      • Market Snippet, By Therapeutic Area
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Reimbursement Scenario
    • Merger and Acquisition Scenario
    • PEST Analysis
  4. Global Compounding Pharmacies Market, By Products, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Oral Medication
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Capsule
        • Tablets
        • Mixtures
        • Lollipops
        • Lozenges
    • Topical Medication
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Gels
        • Ointments
        • Cream
        • Lotions
    • Mouthwashes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Suppositories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Compounding Pharmacies Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Medication for Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Medication for Veterinary
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Medication for Children
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Medication for Geriatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Compounding Pharmacies Market, By Therapeutic Area, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Pain Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hormone Replacement Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Compounding Pharmacies Market, By Therapeutic Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Products, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Products, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Products, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Products, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Products, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Products, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Therapeutic Area, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Central Admixture Pharmacy Services *
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fagron
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fresenius Kabi AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • PharMEDium Services, LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Institutional Pharmacy Solutions
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cantrell Drug Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Triangle Compounding Pharmacies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Lorraine’s Pharmacy
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 36 market data tables and 30 figures on "Compounding Pharmacies Market” - Global forecast to 2027.

Frequently Asked Questions

The global compounding pharmacies market is estimated to reach US$ 13,304.8 Mn, in terms of value by the end of 2027.
Major players operating in the global compounding pharmacies market include Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, and Lorraine’s Pharmacy.
Increasing restrictions on manufacturing of complex formulations and rising number of product recall are the major factors that are expected to hamper growth of the market over the forecast period.
Shortage of essential drugs across the globe, coupled with increasing prevalence of chronic diseases are the major factors that are expected to propel growth of the market over the forecast period.
Development of innovative pain management compounded drugs, constituting of unique and currently unapproved combinations is one of the trends that has been observed in the market
Among regions, North America held a dominant position in the global compounding pharmacies market in 2018, accounting for 65.5% share in terms of value, followed by Europe.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner